Oncology research

Predicting esophageal cancer response to immunotherapy using oxidative stress markers

Updated

Abstract

A risk score (RS) model was developed to predict the prognosis of esophageal squamous cell carcinoma (ESCC) based on oxidative stress-related genes.

  • Survival rates were lower in high-risk groups compared to low-risk groups as determined by the RS model.
  • The model demonstrated strong predictive performance, with an area under the curve (AUC) verified in two cohorts.
  • Independent prognostic analysis identified the RS as an independent risk factor for ESCC.
  • Increased expression of five specific genes (MPC1, COX6C, CYB5R3, CASP7, and CYCS) was detected in esophageal cancer patients.
  • The nomogram developed from the RS provides favorable predictive value for the prognosis of ESCC patients.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

The authors declare that they have no conflicts of interest to report regarding the present study.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free